RecruitingNCT03825458
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.
Sponsor
Hospices Civils de Lyon
Enrollment
3,500 participants
Start Date
Feb 25, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
The " CirB-RNA " cohort aims to create a biological collection associated with clinical and biological data from patients with hepatitis B infection. This project is part of a much larger program that aims to characterize and quantify circulating viral RNAs as a possible new biomarker of hepatitis B functional cure.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Adults patients and minor children over 6 years of age (in Lyon) with acute or chronic hepatitis B or presenting with HBsAg loss (with/without HBs seroconversion). (Co-infected patients with HDV and/or HCV and/or HIV are eligible)
- Patients requiring blood sampling for medical care at the time of the medical appointment.
- Informed patients who do not refuse to participate.
- Persons not affiliated to a social security scheme and persons receiving medical assistance from the state may be asked to participate in the study
Exclusion Criteria4
- Patients participating at the time of the inclusion to an interventional trial evaluating a drug likely to interfere with this study.
- Persons deprived of their liberty by a judicial or administrative decision
- Adults who are subject to a legal protection measure
- Children less than 6 years old (in Lyon)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERBlood sampling
Blood sampling at each clinical follow-up visit.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03825458
Related Trials
Evaluation of Patients With Liver Disease
NCT000019711 location
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
NCT051818267 locations
Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
NCT068341781 location
Real World Assessment of People Living With Chronic Hepatitis B in Australia
NCT0491461119 locations
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
NCT039333841 location